- Home
- HUMA vs BAFN Comparison
HUMA vs BAFN Comparison
Compare HUMA & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUMA | BAFN |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.7M | 175.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HUMA | BAFN |
|---|---|---|
| Price | $0.41 | $6.85 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.63 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 103.5K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.37 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,038,000.00 | N/A |
| Revenue This Year | $72.32 | N/A |
| Revenue Next Year | $518.79 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $4.26 |
| 52 Week High | $1.78 | $9.80 |
Technical Indicators
Market Signals| Indicator | HUMA | BAFN |
|---|---|---|
| Relative Strength Index (RSI) | 36.62 | 50.60 |
| Support Level | $0.34 | $5.98 |
| Resistance Level | $0.75 | $6.96 |
| Average True Range (ATR) | 0.04 | 0.62 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 39.45 | 58.04 |
Price Performance
Historical ComparisonAbout HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company that operates through its wholly owned subsidiary. The Company generates the majority of its revenue from interest on loans and noninterest income. The primary sources of funding for its loans are loan payments, deposits, and borrowings. It is dependent on noninterest income, which is derived from net gain on the sales of the guaranteed portion of government-guaranteed loans and service fee income. The company provides personal banking and business banking services.